CLYM (Climb Bio Inc.) Net Profit

CLYM (Climb Bio) - company brandmark

Climb Bio Inc (CLYM) is a biotechnology business developing methods to combat immune failures amidst a shortage of effective long-term solutions. The asset value tracked on this chart is fixed at -0.06, illustrating profit dynamics. The enterprise's financial success relies on the efficacy of B-lymphocyte therapy for individuals with severe pathologies, where insurance providers will serve as the primary sources of payment.

CLYM (Climb Bio Inc) Net Profit history from 10/04/2024 to 10/29/2026

Analytical breakdowns and data insights for company Climb Bio (CLYM)

- price and consensus price forecast:
Stock Quotes Climb Bio, Inc|CLYM - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Climb Bio, Inc|CLYM - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Climb Bio|CLYM - Book Capitalization|Market Capitalization to Book Value climbbio.com|CLYM - Aggregate Company Assets
- debt and solvency information:
Total Debt to Equity Ratio Climb Bio Inc|CLYM - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Climb Bio Inc.|CLYM - Company Total Debt|Debts to Book Capitalization Climb Bio, Inc|CLYM - Company Long-Term Debt|Company Short-Term Indebtedness Climb Bio|Immediate Liquidity climbbio.com
- net income and valuation multiples indicators:
CLYM - Net Profit
Summary company analysis:Climb Bio Inc
Core merchandise of Climb Bio, Inc.

Geopolitical barriers and sanctions hinder Climb Bio Inc (CLYM) from accessing chemical substances and international trials. This price action directly reflects the company's net income dynamics, capturing the real momentum of capital movement. The stable plateau of this metric signals a potential freeze of funds, masking the risks of a prolonged decline. This indicator clears the picture of speculation, revealing the true profit vector. The horizontal trend here foreshadows either a breakthrough or a deep liquidity crisis.

Main competitors

Net Income argenx BVBA|BNTX (BioNTech SE) - Net Profit|Net Profit Abivax Pharma|Net Income ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Final Profit|Net Profit IMVT (Immunovant Corp)|Net Financial Result Kiniksa Corp (KNSA)|GRFS - Company Net Income|adaptivebiotech.com (ADPT) - Net Income|Celldex Therapeutics, Inc. (CLDX) - Company Net Income|Net Income Aurinia Pharmaceuticals Inc|Net Income BCRX|Net Profit Vera Corp|Company Net Income Dianthus Therapeutics (DNTH)|pharvaris.com - Company Profit|Net Profit ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Company Net Income|Intrexon - Net Profit|Pharming Corp (PHAR) - Net Income|Nektar Therapeutics (NKTR) - Company Net Income|UPB (upstreambio.com) - Company Net Income|ZBIO (Zenas Biopharma) - Net Profit|Immunome Inc (IMNM) - Net Financial Result|Company Net Income Gossamer Corp (GOSS)|Net Income KalVista Corp KALV|Net Profit SEPN (Septerna Inc)|pieris.com - Company Net Income|SVRA: Net Income|Final Profit RIGL (Rigel Pharma)|ANAB: Net Profit|ATXS (Astria Corp) - Company Net Income|ENGN (enGene Holdings Inc.) - Net Profit|rapt.com (RAPT) - Net Financial Result|Company Net Income Aerovate Therapeutics Inc (JBIO)|ACRS - Company Net Income|Kyverna - Net Income|Final Profit TLSA|Cabaletta Bio, Inc. - Net Profit|Net Financial Result ventyxbio.com VTYX|Theratechnologies (THTX) - Company Net Income|Company Profit AVTX|ELDN (Eledon) - Net Profit|Net Income Agenus, Inc (AGEN)|Net Profit ZURA|Net Income atyrpharma.com ATYR|Company Net Income Adagene Inc. ADAG|ImageneBio - Company Net Income|STTK: Net Income|Company Net Income Equillium, Inc.|connectbiopharm.com (CNTB) - Company Net Income|Net Income Immunic|Company Net Income Atara Biotherapeutics, Inc.|InflaRx GmbH - Profit After Tax|Net Profit XFOR|ACET (adicetbio.com) - Final Profit|Net Profit CELU (Celularity)|Net Profit inmunebio.com INMB|BRNS - Company Net Income|Final Profit KZR (Kezar Life Sciences Inc.)|SAB Biotherapeutics, Inc (SABS) - Company Net Income|Net Income Akari Therapeutics, Plc|ENLV (Enlivex Therapeutics Ltd) - Net Profit|Net Profit Q32 Bio Corp|Net Income GOVX (GeoVax)|EDSA (Edesa Biotech Inc) - Final Profit|Net Profit IBIO (iBio Corp)|Net Financial Result Carisma Therapeutics Inc (CARM)|XTLB - Company Net Income|Bolt Biotherapeutics (BOLT) - Net Income|hcwbiologics.com (HCWB) - Company Net Income|Net Income Aptevo Therapeutics Inc.|Net Income AIM|Net Profit Aditxt Corp|Company Net Income GRI Bio, Inc. (GRI)|xortx.com - Company Profit|Net Profit HIND (Vyome Holdings)|Revelation Biosciences Inc (REVB) - Company Net Income|Indaptus - Net Profit|BiondVax Pharmaceuticals (SCNI) - Net Income|calcimedica.com (CALI) - Company Net Income|AFMD (Affimed N.V.) - Company Net Income|ALLK (Allakos Inc) - Net Profit|HOOKIPA (HOOK) - Net Financial Result|Company Net Income IGM Biosciences, Inc. (IGMS)|Net Income iTeos Pharma ITOS|Net Profit OCEA (Ocean Biomedical, Inc.)|tcbiopharm.com - Company Net Income|THRD: Net Income